Research & Development
The main aim of Spiro Organics is to develop the cost-effective, robust, and atom economic catalytic asymmetric transformations for the synthesis of API intermediates and other chiral building blocks.
Our Specialised Products
Novel commercialization of the BINOL-derived cyclopentadienyl Rh(I) catalyst. Spiro Organics developed decent technology for the chiral BINOL-derived cyclopentadienyl Rh(I) bis ethylene complexes without using toxic thallium salts.
Our Business Model
Contract research & Custom synthesis. Process development for API Intermediates & synthesis of API impurities. Commercialization of novel ligands and catalysts Design and synthesis of novel scaffolds to access library Molecules for various biological targets in drug discovery programme.
